Tenax Therapeutics, Inc.
TENX
$5.80
$0.030.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 94.85M | 98.31M | 9.38M | 12.55M | 9.79M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.77M | 1.44M | 1.18M | 1.84M | 1.64M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 64.00K | 33.90K | 50.30K | 66.60K | 252.00K |
| Total Current Assets | 96.69M | 99.78M | 10.62M | 14.46M | 11.68M |
|
|
|||||
| Total Current Assets | 96.69M | 99.78M | 10.62M | 14.46M | 11.68M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 1.10K | 1.10K | 1.10K | 1.00K |
| Total Assets | 96.69M | 99.78M | 10.62M | 14.46M | 11.69M |
|
|
|||||
| Total Accounts Payable | 3.16M | 1.58M | 869.70K | 1.08M | 2.07M |
| Total Accrued Expenses | 1.54M | 977.50K | 592.40K | 536.40K | 1.01M |
| Short-term Debt | -- | -- | 278.80K | 413.20K | 501.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.69M | 2.56M | 1.74M | 2.03M | 3.59M |
|
|
|||||
| Total Current Liabilities | 4.69M | 2.56M | 1.74M | 2.03M | 3.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 278.80K | 413.20K | 501.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.69M | 2.56M | 1.74M | 2.03M | 3.59M |
|
|
|||||
| Common Stock & APIC | 406.85M | 405.81M | 313.50M | 313.48M | 305.35M |
| Retained Earnings | -314.86M | -308.59M | -304.63M | -301.05M | -297.25M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 91.99M | 97.22M | 8.88M | 12.43M | 8.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 91.99M | 97.22M | 8.88M | 12.43M | 8.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 91.99M | 97.22M | 8.88M | 12.43M | 8.10M |
|
|
|||||